Review paper
Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted?
Volume: 28, Issue: 3, Pages: 456 - 457
Published: Mar 1, 2022
Abstract
We have recently reported that outcomes evaluated in interventional randomized controlled trials (RCTs) for coronavirus disease 2019 (COVID-19) vary significantly [[1]Mathioudakis A.G. Fally M. Hashad R. Kouta A. Hadi A.S. Knight S.B. et al.Outcomes evaluated in controlled clinical trials on the management of COVID-19: a methodological systematic review.Life. 2020; 10: 350PubMed Google Scholar]. This complicates the interpretation of results,...
Paper Details
Title
Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted?
Published Date
Mar 1, 2022
Volume
28
Issue
3
Pages
456 - 457
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History